VITAL KSK HOLDINGS,INC. [3151.T]
TOKYO, May 14 (Pulse News Wire) – Vital KSK Holdings,inc. (3151.T) plans to issue performance-based restricted share awards to its executives and employees based on the approval received at its 14th Ordinary General Meeting of Shareholders held on June 29, 2023.
According to the plan, the total amount payable for the issuance of self-owned shares as part of the compensation program is expected to be ¥53.5 million. Under the scheme, eligible recipients will receive stock grants contingent upon achieving certain performance targets set during the fiscal year ending March 31, 2026. The distribution period for directors and executive officers without audit committee membership or external directorship is from April 1, 2025, to March 31, 2026. For subsidiary directors, executive officers, and targeted employees, the evaluation period aligns with their respective fiscal years within the same timeframe.
Additionally, the company will impose restrictions on transferring these shares until July 25, 2026, or July 1, 2027, if the recipient leaves their position before June 30, 2027. During this restriction period, recipients cannot sell, pledge, gift, or otherwise dispose of the awarded shares. In cases where recipients leave their positions due to valid reasons recognized by the board of directors, the company will acquire the restricted shares free of charge. Furthermore, if any restrictions remain unlifted beyond the initial period, the company will also acquire those shares The valuation basis for the share price used in the issuance is determined by the simple average closing price of the company's ordinary shares traded on the Tokyo Stock Exchange over the month preceding the board resolution date, specifically from May 25, 2026, to June 24, 2026.
This approach ensures a fair and non-arbitrary pricing mechanism.
🟢 Confidence: High AI-translated content.